CALEC Cell Therapy Repairs Corneal Damage in Phase I Study

19Report
CALEC Cell Therapy Repairs Corneal Damage in Phase I Study

Researchers headed by a team at Mass Eye and Ear, Harvard Medical School, reported positive data from a Phase I clinical study evaluating a stem cell treatment known as cultivated autologous limbal epithelial cell transplantation (CALEC), in patients with significant chemical burns in one eye.

Similar news

Share
Report

Report this article here.